WHO: Amid short supplies, vaccine doses can be 6 weeks apart

By: |
January 08, 2021 6:22 PM

The agency said this pragmatic approach could be considered as a response to exceptional epidemiological circumstances.

The agency also said it also does not recommend COVID-19 vaccination of travelers unless they face high risks or qualify as priority cases.The agency also said it also does not recommend COVID-19 vaccination of travelers unless they face high risks or qualify as priority cases.

World Health Organisation experts on Friday issued recommendations that the interval between administration of two doses of the Pfizer-BioNTech vaccine against the coronavirus can be extended to up to six weeks.

WHO’s Strategic Advisory Group of Experts on immunisation, known as SAGE, formally published its advice after a full review of that vaccine, which is the first to get emergency approval from the UN health agency to fight the COVID-19 pandemic. It said an interval of 21 to 28 days between the doses is recommended.

But the UN health agency also noted that a number of countries face exceptional circumstances of vaccine supply constraints combined with a high disease burden, and said some have been considering delaying the administration of a second dose as a way to broaden initial coverage.

The agency said this pragmatic approach could be considered as a response to exceptional epidemiological circumstances.

WHO’s recommendation at present is that the interval between doses may be extended up to 42 days (6 weeks), on the basis of currently available clinical trial data, it said, adding: Should additional data become available on longer intervals between doses, revision of this recommendation will be considered.

Hard-hit Britain, for example, has decided to delay for as much as 12 weeks and data from that expansion could help contribute to possible revisions in the WHO recommendation, said WHO spokeswoman Dr. Margaret Harris.

In the recommendations, WHO added that countries seeking to extend the interval should make sure that vaccinated patients can still have access to a second dose.

The agency also said it also does not recommend COVID-19 vaccination of travelers unless they face high risks or qualify as priority cases.

WHO also said symptomatic reinfection by the coronavirus within six months of a first infection is rare, so people who have had the illness within the previous six months may delay vaccination until near the end of this period.

WHO said there was currently no evidence on the need for a booster dose, and said there was no data available on the interchangeability of the Pfizer-BioNTech vaccine with other COVID-19 vaccines. It also cited a lack of evidence about whether vaccination reduces the risk of transmission of the virus to other people.

Get live Stock Prices from BSE, NSE, US Market and latest NAV, portfolio of Mutual Funds, Check out latest IPO News, Best Performing IPOs, calculate your tax by Income Tax Calculator, know market’s Top Gainers, Top Losers & Best Equity Funds. Like us on Facebook and follow us on Twitter.

Financial Express is now on Telegram. Click here to join our channel and stay updated with the latest Biz news and updates.

Next Stories
1American vaccines effective against COVID strain first found in India: US officials
2Coronavirus Cases in India Live News: Hope or illusion? India’s Covid-19 positivity rate declining; infections down in 200 districts
3US civil rights leader to urge Joe Biden to release 60 million COVID vaccine doses to India